Search research articles
Contact Us
Filters
Showing results (41-50 of 46) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 46 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 25, 2017
α- Versus β-Emitting Radionuclides for Pretargeted Radioimmunotherapy of Carcinoembryonic Antigen-Expressing Human Colon Cancer Xenografts
Sandra Heskamp, Reinier Hernandez, Janneke D M Molkenboer-Kuenen, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 13, 2018
Treatment of carcinoma in situ of the urinary bladder with an alpha-emitter immunoconjugate targeting the epidermal growth factor receptor: a pilot study
Michael E Autenrieth, Christof Seidl, Frank Bruchertseifer, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 9, 2012
Enhanced efficacy of combined 213Bi-DTPA-F3 and paclitaxel therapy of peritoneal carcinomatosis is mediated by enhanced induction of apoptosis and G2/M phase arrest
Mario Vallon, Christof Seidl, Birgit Blechert, et al.
Oncotarget
|
January 11, 2015
α-Radioimmunotherapy with ²¹³Bi-anti-CD38 immunoconjugates is effective in a mouse model of human multiple myeloma
Katharina Teiluf, Christof Seidl, Birgit Blechert, et al.
European Urology
|
December 9, 2020
Activity and Adverse Events of Actinium-225-PSMA-617 in Advanced Metastatic Castration-resistant Prostate Cancer After Failure of Lutetium-177-PSMA
Benedikt Feuerecker, Robert Tauber, Karina Knorr, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 31, 2021
Synthesis and Preclinical Evaluation of a <sup>68</sup>Ga-Labeled Adnectin, <sup>68</sup>Ga-BMS-986192, as a PET Agent for Imaging PD-L1 Expression
Stephanie Robu, Antonia Richter, Dario Gosmann, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 46) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 46 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 25, 2017
α- Versus β-Emitting Radionuclides for Pretargeted Radioimmunotherapy of Carcinoembryonic Antigen-Expressing Human Colon Cancer Xenografts
Sandra Heskamp, Reinier Hernandez, Janneke D M Molkenboer-Kuenen, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 13, 2018
Treatment of carcinoma in situ of the urinary bladder with an alpha-emitter immunoconjugate targeting the epidermal growth factor receptor: a pilot study
Michael E Autenrieth, Christof Seidl, Frank Bruchertseifer, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 9, 2012
Enhanced efficacy of combined 213Bi-DTPA-F3 and paclitaxel therapy of peritoneal carcinomatosis is mediated by enhanced induction of apoptosis and G2/M phase arrest
Mario Vallon, Christof Seidl, Birgit Blechert, et al.
Oncotarget
|
January 11, 2015
α-Radioimmunotherapy with ²¹³Bi-anti-CD38 immunoconjugates is effective in a mouse model of human multiple myeloma
Katharina Teiluf, Christof Seidl, Birgit Blechert, et al.
European Urology
|
December 9, 2020
Activity and Adverse Events of Actinium-225-PSMA-617 in Advanced Metastatic Castration-resistant Prostate Cancer After Failure of Lutetium-177-PSMA
Benedikt Feuerecker, Robert Tauber, Karina Knorr, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 31, 2021
Synthesis and Preclinical Evaluation of a <sup>68</sup>Ga-Labeled Adnectin, <sup>68</sup>Ga-BMS-986192, as a PET Agent for Imaging PD-L1 Expression
Stephanie Robu, Antonia Richter, Dario Gosmann, et al.
Page
of 5